| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | JUNO THERAPEUTICS INCORPORATED | 1,375,000 | 73,329,000 | 37.02% | ||
| 2 | PARATEK PHARMACEUTICALS INC | 2,138,872 | 55,119,000 | 27.83% | ||
| 3 | Egalet Corp | 2,645,558 | 38,175,000 | 19.27% | ||
| 4 | FIBROGEN INC COM | 972,175 | 22,846,000 | 11.54% | ||
| 5 | Proteon Therapeutics | 250,000 | 4,465,000 | 2.25% | ||
| 6 | Dicerna Pharmaceuticals | 223,457 | 3,117,000 | 1.57% | ||
| 7 | ACHAOGEN INC COM | 166,450 | 1,004,000 | 0.51% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-15-008290, filed 2015.08.10).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
